FP&A transformation helps $1.5B global Biopharmaceutical company drive efficiency

Business Challenges

  • Business Transition – Significant increase in the number of programs, projects, and trials that need to be actively planned, managed, reported against, and analyzed
  • Inability to Link Operational Plans with Financial Forecasts – Inability to link dynamically changing project-based clinical development plans with financial plans
  • Heavy Manual Effort – Revenue planning, product costing, and product P&L’s were supported by disconnected Excel models, required intensive manual effort to maintain and update, and required significant data manipulation
  • Outdated EPM Platform – Solid foundation platform had not been substantially updated in seven years and no longer optimally supported evolving business model


  • Mobilization – Conducted short-cycle planning and reporting Mobilization to define business requirements, understand issues and opportunities, envision the future, identify key initiatives, and create a go-forward roadmap
  • Solution Upgrade – Enhanced business capabilities by upgrading to the current version of Oracle-Hyperion EPM solution
  • Solution Optimization – Automated hierarchy management, historical data cube, enhanced business views, improved maintenance and support


  • Increased Efficiency – Reduced planning, reporting, and analysis cycle times.  Significant reduction in manual effort and workarounds
  • Increased Effectiveness – Achieved consistency, standardization, automation, and enhanced system flexibility
  • Transformational Roadmap Developed – Future state FP&A vision and intentional go-forward transformation roadmap.

Complimentary Discovery Briefing

What are you interested in?
This field is for validation purposes and should be left unchanged.